Business Context and Reporting Period
Agape ATP Corp. filed a transition report covering July 1–December 31, 2019, following a change in fiscal year-end from June 30 to December 31. The company sells health and wellness products and related advisory services, primarily in Malaysia, through subsidiaries in Labuan and Hong Kong. Its products are sourced from third parties and rebranded by the company.
Financial Performance and Position
Amounts are in U.S. dollars. The six-month results below compare the transition period with the six months ended December 31, 2018.
| Metric | Six months ended Dec. 31, 2019 | Six months ended Dec. 31, 2018 |
|---|---|---|
| Revenue | $429,362 | $685,288 |
| Gross profit / margin | $45,883 / 10.7% | $65,933 / 9.6% |
| Operating expenses (SG&A) | $312,270 | $63,068 |
| Operating loss | $(266,387) | Income of $2,865 |
| Net loss | $(338,931) | $(142,446) |
| Net cash used in operating activities | $(113,945) | $(76,591) |
Revenue declined about 37% year over year, attributed to lower promotional activity by the related-party customer. Gross margin improved by about 1.1 percentage points, which management attributed to a modest selling-price increase. SG&A rose about $249,000, mainly from higher U.S. and Hong Kong professional fees and CEO travel.
At December 31, 2019, total assets were $4.34 million, total liabilities $83,988, and stockholders’ equity $4.25 million. Working capital was $3.45 million. Cash and cash equivalents were $2.74 million, including $2.51 million of bank time deposits; cash in bank alone was $238,937. The company reported no credit facilities or significant off-balance-sheet arrangements. It said available cash should fund operations for 12 months from report issuance, while expansion could require additional capital.
The company recorded a $68,391 unrealized loss on marketable securities in the period after adopting fair-value accounting. It reported no income-tax provision for the period. No dividends are planned.
Material Changes, Outlook, and Risks
- All six-month 2019 revenue came from Agape S.E.A. Sdn Bhd, the company’s sole customer and a related party controlled by CEO How Kok Choong. The related-party receivable was $520,786 at period-end, up from $433,338 at June 30, 2019; no allowance was recorded.
- Two suppliers accounted for all purchases during the six-month period (59% and 41%). The filing discloses minimum purchase commitments totaling $5.55 million over the stated schedule, but says the vendor was unable to meet the minimum commitment because manufacturing was delayed.
- Management described COVID-19, Malaysia’s lockdown, and possible sourcing and delivery disruptions as material uncertainties. The financial impact could not be estimated; management warned revenue might not grow or remain at comparable levels in the following three quarters of 2020 and that investment values could decline further.
- Management expected the customer’s planned e-commerce platform and online recruitment to support demand, and discussed potential expansion into Thailand, Indonesia, and Taiwan. No firm expansion timetable or budget was set; the company had no salesforce or employees other than its sole officer and director as of the report date.
- The company reported plans to develop additional products and evaluate acquisitions, but stated that research, testing, staffing, and expansion would require resources. It currently relies on third-party products and has no product R&D expenditures for the last two fiscal years.
- Management concluded internal control over financial reporting was ineffective at December 31, 2019, identifying material weaknesses in accounting staffing and expertise, internal audit, and segregation of duties/risk assessment. Remediation was planned, with implementation expected at least partly by fiscal 2020 year-end.
- A March 2, 2020 agreement to sell the company’s 17.86% interest in Unreserved Sdn Bhd to the CEO at its December 31, 2019 carrying value of $730,637 is a subsequent related-party transaction.
The independent auditor gave an unqualified opinion on the consolidated financial statements for the six-month period ended December 31, 2019; the auditor did not express an opinion on internal-control effectiveness. The filing reports no pending legal proceedings considered materially adverse.
Most Important Facts to Verify
- Collection timing and recoverability of the $520,786 receivable from the CEO-controlled sole customer, and the basis for recording no doubtful-account allowance.
- Current status, enforceability, and potential financial consequences of the $5.55 million purchase commitments, particularly given the reported vendor production delay.
- Liquidity availability and restrictions on the $2.51 million in time deposits, and the assumptions supporting management’s 12-month cash runway statement.
- Valuation and subsequent performance of marketable and non-marketable investments, including the proposed sale of Unreserved Sdn Bhd to the CEO.
- Progress on remediating the disclosed material weaknesses and strengthening board independence, audit oversight, and related-party transaction controls.
- Actual effects of COVID-19 on customer demand, supply continuity, receivable collection, and the company’s expansion plans.
- Period-comparison and audit-status details: the filing presents a six-month transition period, not a standalone fourth quarter, and certain comparative interim figures are identified as unaudited.